Global Hemostatic Powder Market Growth 2023-2029

Global Hemostatic Powder Market Growth 2023-2029

The global Hemostatic Powder market size is projected to grow from US$ 378 million in 2022 to US$ 471.7 million in 2029; it is expected to grow at a CAGR of 471.7 from 2023 to 2029.

Market competition is intense. Johnson & Johnson, C. R. Bard, Pfizer, CSL Behring and Gelita Medical, etc. are the leaders of the industry, with about 70% market shares.

North America is the largest consumption place, with a consumption market share nearly 40%. Following North America, Europe is the second largest consumption place with the consumption market share of 30%.

The classification of hemostat powder includes gelatin, fibrin, cellulose and the proportion of gelatin is about 38%.

Hemostat Powder is widely used in surgical wound care and general wound care. The most proportion of hemostat powder is used in surgical wound care, and the proportion is 66%.

When blood vessel walls are disrupted during surgeries, there are occurrences of blood loss, which needs to get coagulated. This process of blood clot formation at the site of injury is known as hemostasis. Hence, hemostats offer temporary blockage by forming blood clot to control bleeding.

Hemostat powder is product in form of powder.

LPI (LP Information)' newest research report, the “Hemostatic Powder Industry Forecast” looks at past sales and reviews total world Hemostatic Powder sales in 2022, providing a comprehensive analysis by region and market sector of projected Hemostatic Powder sales for 2023 through 2029. With Hemostatic Powder sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Hemostatic Powder industry.

This Insight Report provides a comprehensive analysis of the global Hemostatic Powder landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Hemostatic Powder portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Hemostatic Powder market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Hemostatic Powder and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Hemostatic Powder.

This report presents a comprehensive overview, market shares, and growth opportunities of Hemostatic Powder market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
Absorbable Hemostatic Agent
Not Absorbable Hemostatic Agent

Segmentation by application
Hospital
Clinics
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Johnson & Johnson
BD
Baxter
B.Braun
Cura Medical
GELITA MEDICAL
Curasan AG
Meril Life Sciences
Zhonghui Shengxi
Beijing Datsing Bio-tech
Guizhou Jin Jiu Biotech
Beijing Taikesiman
Foryou Medical
Saikesaisi Holdings Group
Biotemed

Key Questions Addressed in this Report

What is the 10-year outlook for the global Hemostatic Powder market?

What factors are driving Hemostatic Powder market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Hemostatic Powder market opportunities vary by end market size?

How does Hemostatic Powder break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.